Barnwell Industries (BRN) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Oct, 2026Executive summary
Q3 continuing-operations revenue was $3.192M; net loss attributable to shareholders was $1.550M. Nine-month revenue was $10.695M.
Contract drilling was sold in March 2025 and classified as discontinued operations; the August sale of all U.S. oil and gas interests ends U.S. oil and gas ownership.
Financial highlights
Q3 revenue fell from $4.506M a year earlier; nine-month revenue fell from $14.346M.
Q3 G&A rose $565K YoY, including $657K of dispute-related fees, partly offset by a $348K estimated insurance recovery.
Q3 ceiling-test impairment was $200K versus $599K YoY; nine-month impairment was $865K versus $2.276M.
Continuing-operations operating cash flow was negative $1.163M for nine months versus positive $4.349M a year earlier; cash was $1.154M at June 30, 2025, with a $1.321M working capital deficit.
Outlook and guidance
FY2025 oil and gas capital investment estimate was $800K–$1.0M, subject to cash flows and management’s assessment of the oil and gas environment.
Further ceiling-test impairment may occur in Q4 FY2025 due to lower expected reference oil prices; the potential charge was not yet estimable.
An estimated $700K after-tax loss on the U.S. asset sale is expected in the quarter ending September 30, 2025.
U.S. sale proceeds are intended for Twining workovers and optimization and to help reduce the working capital deficit; additional capital will be needed for development.
Latest events from Barnwell Industries
- Key votes center on expanding equity awards and ratifying grants above existing limits.BRN
Proxy filing - A disputed director slate, pending litigation and a rights plan frame the 2025 vote.BRN
Proxy filing - Proxy dispute delays the meeting; shareholders face four Board nominees and auditor ratification.BRN
Proxy filing - A 29.90% shareholder group presses for five board seats amid litigation and a consent drive.BRN
Proxy filing - Board opposes Sherwood’s bid to replace all directors and roll back bylaw changes.BRN
Proxy filing - A $50M shelf accompanies resale registration for 3.25M shares and warrant shares.BRN
Registration filing - A 29.90% shareholder group seeks a board overhaul and operational turnaround.BRN
Proxy filing - 2025 proxy fight centers on board control, strategy, and Sherwood's consent campaign.BRN
Proxy filing - Lower prices, production declines and impairment drove a wider Q1 loss as cash fell to $1.957M.BRN
Q1 2025